This is interesting, and I don't know whether it belongs in this posting, but
I have AS that is caused by a different bacterium than any mentioned here--and a
different focus of infection.
Professor (emeritus) Alan Ebringer, Kings College devised a test to
differentiate RA from AS and found that every subject with RA had a pathogen not
mentioned here. Later, he studied BSE and this may have led to a breakthrough
in MS research; Mad Cow is apparently an autoimmune disease, and not caused by
prions. The professor has suggested that he will eat any steak (best cuts,
please) from any certified Mad Cow.
These diseases may be due to a molecular mimicry reaction that causes the
autoimmune response:
RA: Usually after a UTI due to Proteus mirabilis (majority of UTIs are E.
coli) and elevated IgG-Pm can be measured; focus of infection is urinary tract
and most common in tissue types HLA DR 1/DR4.
AS/ReA/CD: Due to LGS and reaction to Klebsiella pneumoniae--elevated IgA-Kp
focus of infection is entire digestive system, but typical lesions are at the
ileocecal junction (higher for Crohn's and lower for Reiter's).
MS/BSE/kuru/vCJD: Acinetobacter calcoaceticus may infect the sinus cavities
and cause an immunoglobulin response that results in systemic neurological
damage. In aggressive forms of MS, such as vCJD there may be other bacteria
involved or a more susceptible genetic component. Other pathogens have been
suspected in MS, and treated, in certain individuals, with some success using
powerful broad-spectrum antibiotics.
I am glad that some of this information is being studied, but just wondering
about the germ connection with RA, and I don't want to discount Dr. Brown's
discoveries or the work of those physicians following his successes. I have
only proven the AS-Kp connection for myself, although others have done Giraud
Campbell's regimen for 'arthritis' and have had success with this type of
anti-inflammatory diet. Certainly, diet and lifestyle are major components in
many or most chronic diseases.
Best Regards,
John
Mycoplasma Registry GWI&CFS <mycoreg@...
Recommendations for PCR tests and/or culture for the following
pathogens found in patients with lower urinary tract symptoms (LUTS)
and Rheumatoid Arthritis (RA), systemic lupus erythematosus (SLE),
Sjögren's syndrome (SS), Graves disease, autoimmune diseases as well
as Chronic Fatigue Syndrome/Gulf War Syndrome:
Mycoplasma hominis
Mycoplasma genitalium
Ureaplasma urealyticum
Escherichia coli
Gardnerella vaginalis
Streptococcus agalactiae
Chlamydia trachomatis
* * * * * * * * * * * * * * * * * * * * * * * * * * *
MYCOPLASMA REGISTRY REPORTS
for gulf war syndrome & chronic fatigue syndrome
© 2006 Sean Dudley & Leslee Dudley. All rights reserved.
* * * * * * * * * * * * * * * * * * * * * * * * * * *
Rheumatoid Arthritis May Be Related To Lower Urinary Tract Symptoms
(LUTS)
By Philip M. Hanno MD, MPH
Medical News Today (press release) - UK - July 10,2006
http://www.medicalnewstoday.com/medicalnews.php?newsid=46693
Patients with systemic lupus erythematosus (SLE), Sjögren's syndrome
(SS), and Graves disease
are reported to be associated with an increased severity of LUTS
compared with control populations. Peeler's recent report that in a
survey of 222 patients with interstitial cystitis, RA was the second
most common IC-associated disease, occurring in more than 13% of his
patients (Scand J Urol Nephrol 37:60-63, 2003), stimulated Lee and
colleagues to look for a relationship between RA and LUTS.
Urinary symptoms, including IC-like symptoms, were investigated in a
cohort of patients with RA. Results were compared with a group of age-
matched controls. Patients with urinary tract infection and those on
medications that could induce oral or ocular dryness were excluded
from the analysis. One hundred eighty-nine patients were compared
with 679 controls. AUA symptom scores and percentage of individuals
reporting severe LUTS (AUA score
Likewise, there was no significant difference in patients reporting
IC-like symptoms as per the O'Leary Sant Interstitial Cystitis
Symptom Index. Multivariate regression analysis did reveal that SS
was significantly correlated with severe LUTS as per the AUA Symptom
Index. There was a trend toward a higher score on the O'Leary Sant
Symptom Index in patients with SS, but this did not reach statistical
significance.
The authors conclude that RA does not by itself predispose to
increased severity of LUTS. Patients with secondary SS do have more
severe LUTS. This is an excellent study. One wonders whether some
symptoms suggestive of PBS/IC may have been masked by treatment for
RA that was ongoing in these patients.
Reference: Scand J Rheumatol 35:96-101, 2006
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?
db=pubmed&cmd=Retrieve&dopt=Abstract&list_uids=16641041&query_hl=4&ito
ol=pubmed_DocSum
UroToday - the only urology website with original content written by
global urology key opinion leaders actively engaged in clinical
practice. To access the latest urology news releases from UroToday,
go to: http://www.urotoday.com
Copyright © 2006 - UroToday
* * * * * * * * * * * * * * * * * * * * * * * * * * *
Lower urinary tract symptoms in female patients with rheumatoid
arthritis.
Lee KL, Chen MY, Yeh JH, Huang SW, Tai HC, Yu HJ.
Department of Internal Medicine, National Taiwan University Hospital
and College of Medicine, Taipei, Taiwan.
Scand J Rheumatol. 2006 Mar-Apr;35(2):96-101.
OBJECTIVE: Patients with autoimmune diseases such as systemic lupus
erythematosus (SLE) and Sjogren's syndrome (SS) are associated with
an increased severity of lower urinary tract symptoms (LUTS).
Recent surveys also reveal that rheumatoid arthritis (RA) is
prevalent in patients with interstitial cystitis (IC). Therefore, we
have investigated LUTS in patients with RA.
METHODS: A total of 198 female patients with RA, aged 40 years or
older, from the rheumatology outpatient clinic completed this
prospective study. The American Urological Association Symptom
Index (AUASI) score was used to assess the severity of LUTS and the
O'Leary-Sant Symptom Index (ICSI) was used to evaluate IC-like
urinary symptoms in these patients, which were compared to those of
679 age-matched controls. The possible associations of clinical
parameters with LUTS were also explored.
RESULTS: The Mean AUASI score and the percentage of individuals
reporting severe LUTS (AUASI score
symptoms (ICSI score
between the RA and control groups. However, in the RA group
multivariate regression analyses identified patients with secondary
SS (n = 21) to be associated with a significantly higher AUASI score
(p = 0.007) and a higher percentage of severe LUTS (p = 0.02); these
were also significantly higher than those of the control group (p =
0.02 and p = 0.01, respectively).
CONCLUSION: Patients with RA have similar urinary complaints when
compared to controls. However, those with secondary SS have a greater
severity of LUTS, a finding similar to that observed in patients with
primary SS.
PMID: 16641041 [PubMed - indexed for MEDLINE]
* * * * * * * * * * * * * * * * * * * * * * * * * * *
[Role of bacteria associated with sexually transmitted infections in
the etiology of lower urinary tract infection in primary care]
[Article in Spanish]
Gonzalez-Pedraza A, Ortiz C, Mota R, Davila R, Dickinson E.
Centro de Salud Dr. Jose Castro Villagrana. Tlalpan. Mexico.
silviala@...
Enferm Infecc Microbiol Clin. 2003 Feb;21(2):89-92.
INTRODUCTION: Urinary tract infections (UTI) are the second most
frequent type of infectious pathology treated in primary care
clinics. The participation of microorganisms associated with sexually
transmitted infection has been reported as a cause of UTI;
nevertheless this concept is still controversial. To gather data on
this subject, we carried out a search for Gardnerella vaginalis,
Ureaplasma urealyticum, Mycoplasma hominis and Streptococcus
agalactiae besides the common microorganisms involved in
UTI. METHODS: A total of 1507 urine cultures from patients with a
clinical diagnosis of low UTI were analyzed. Samples were inoculated
onto 5% sheep blood agar and McConkey agar, as well as HBT medium for
G. vaginalis, and U9B broth and agar E broth for M. hominis and U.
urealyticum.The following parameters were analyzed as possible risk
factors: age, sex, pregnancy and diabetes status.
RESULTS. There were 436 (28.9%) positive urine cultures. Escherichia
coli was isolated in 44.34% of cases. Microorganisms associated with
sexually transmitted disease were found in 162 (37%): G. vaginalis
(25.7%), U. urealyticum (5.9%), S. agalactiae (3.4%) and M. hominis
(2%). UTI were more frequent among the 20 to 40 year-old age group,
in women and in diabetic patients.
CONCLUSIONS: Microorganisms associated with sexually transmitted
disease were found in a large percentage of cultures, indicating the
need for studies to clarify their role in the etiology of UTI.
PMID: 12586032 [PubMed - indexed for MEDLINE]
* * * * * * * * * * * * * * * * * * * * * * * * * * *
[Mepartricine and prostatitis. Clinical experience and rationale for
use][Article in Italian]
Minerva Urol Nefrol. 2001 Sep;53(3):129-33.
Saita A, Morgia G, Branchina A, Giammusso B, Iurato C, Malacasa E,
Motta M.
Divisione Clinicizzata di Nefrologia Chirurgica-Urologia, Universita
degli Studi, Catania, Italy.
BACKGROUND: The purpose of this study was to report our experience on
the use of Mepartricine in the treatment of chronic and sub-acute
prostatitis and to analyse, on the basis of the literature, the role
of estrogens, the target of Mepartricine in the development and
maintenance of prostatic inflammatory reactions.
METHODS: In a retrospective study the data of 110 patients who
presented with lower urinary tract symptoms suggestive of
prostatitis, from January 1994 to February 1999 have been evaluated:
65 of this patients had an abacterial prostatitis, and 45 a bacterial
prostatitis. The Mearers-Stamey test was used to localize
inflammation and pathogens to prostate. The clinical symptoms
presented were essentially pelvic and perineal pain and irritative
and obstructive voiding symptoms. The treatment was based on
antibiotic therapy indicated by the sensitivity to antibiotic assay.
In abacterial prostatitis, in cases of Chlamidia, Mycoplasma and
Ureaplasma positivity, the treatment was based on macrolides and
tetracycline use. All the patients received Mepartricine by oral
supply, 1 daily tablet (40 mg) for 60 days.
RESULTS: After two months of treatment remarkable improvements in
symptoms were obtained despite the persistent bacteriological
positivity in the prostatic secretion in 68% of cases. Therefore
antinflammatory antiedemic and decongestant effects of Mepartricine
on prostatic inflammation, are observed. CONCLUSIONS: The data of the
literature show data estrogens modulate inflammatory reactions: it is
possible that their decrease can produce, at prostatic level,
antinflammatory effects improving urethro-prostatic bladder
functions. Personal experience seems to confirm this supposition and
so we think that Mepartri-cine can be considered and excellent
coadjuvant in the treatment of prostate inflammation, independent of
etiology.
PMID: 11723437 [PubMed - indexed for MEDLINE]
* * * * * * * * * * * * * * * * * * * * * * * * * * *
Cytokine concentrations in seminal plasma from subfertile men are not
indicative of the presence of Ureaplasma urealyticum or Mycoplasma
hominis in the lower genital tract.
Pannekoek Y, Trum JW, Bleker OP, van der Veen F, Spanjaard L, Dankert
J.
Department of Medical Microbiology, Academic Medical Center,
Amsterdam, The Netherlands. y.pannekoek@...
J Med Microbiol. 2000 Aug;49(8):697-700.
The inflammatory response to the presence of Ureaplasma urealyticum
or Mycoplasma hominis in the lower genital tract of subfertile men
without any signs or symptoms of infection was investigated by
measuring the concentrations of interleukin (IL)-6, IL-8, tumour
necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) in
seminal plasma. Semen samples were collected from 30 culture-positive
subfertile males and 23 culture-negative subfertile males. Enzyme-
linked immunosorbent assays showed that IL-8 was present in
relatively high concentrations (0.12-4.8 ng/ml) in all semen samples
investigated. In contrast, the other cytokines were only detectable
in 72% (IFN-gamma), 44% (IL-6) and 19% (TNF-gamma) of the samples and
were present in relatively low concentrations (1-410 pg/ml). Seminal
plasma cytokine concentrations were similar in samples from culture-
positive and culture-negative males. These data strongly indicate
that the presence of U. urealyticum or M. hominis in the lower
genital tract of subfertile males reflects a silent colonisation
rather than infection.
PMID: 10933253 [PubMed - indexed for MEDLINE]
* * * * * * * * * * * * * * * * * * * * * * * * * * *
Association of ureaplasma urealyticum with abnormal reactive oxygen
species levels and absence of leukocytospermia.
Potts JM, Sharma R, Pasqualotto F, Nelson D, Hall G, Agarwal A.
Department of Urology, The Cleveland Clinic Foundation, Cleveland,
Ohio, USA.
J Urol. 2000 Jun;163(6):1775-8.
PURPOSE: Ureaplasma urealyticum is a commensal of the lower
genitourinary tract of many sexually active adults. The organism is
more common in partners of infertile than fertile marriages. We
conducted a prospective study at our tertiary care center to confirm
a possible association between U. urealyticum and abnormal sperm
function parameters.
MATERIALS AND METHODS: A total of 50 consecutive male patients
seeking general urology consultation for lower urinary tract symptoms
characteristic of chronic prostatitis were evaluated. Urine and semen
localization cultures were performed with additional semen cultures
for U. urealyticum, Chlamydia trachomatis and Mycoplasma hominis.
Specimens from 21 healthy men were used as controls. Specimens were
analyzed by a computer assisted semen analyzer, and verified manually
for concentration, percent motility and morphology. Leukocytospermia
was measured by the Endtz test. Semen specimens were also analyzed
for reactive oxygen species (ROS), acrosome reaction and mannose
binding assay. RESULTS: Of the patients 17 had positive U.
urealyticum cultures and the other cultures were negative. Patients
with U. urealyticum had significantly higher ROS levels (log [ROS +
1] = 2.52 +/- 0.25) than those without U. urealyticum (1.49 +/- 0.20,
p = 0.002) or controls (1.31 +/- 0.19, p = 0.002). Leukocytospermia
was detected in only 1 of the 17 (6%) positive specimens and 4 (12%)
negative specimens.
CONCLUSIONS: Seminal ROS levels are elevated among patients with U.
urealyticum. ROS induces lipid peroxidation, which reduces membrane
fluidity and sperm fertilization capability, and may be the mechanism
by which U. urealyticum impairs sperm function. Absence of
leukocytospermia does not exclude U. urealyticum.
PMID: 10799180 [PubMed - indexed for MEDLINE]
* * * * * * * * * * * * * * * * * * * * * * * * * * *
A double-blind, randomized, controlled multicentre study to compare
the efficacy of ciprofloxacin with pivampicillin as oral therapy for
epididymitis in men over 40 years of age.
Eickhoff JH, Frimodt-Moller N, Walter S, Frimodt-Moller C.
Glostrup Hospital, Denmark.
BJU Int. 1999 Nov;84(7):827-34.
OBJECTIVE: To compare the efficacy and safety of ciprofloxacin 500 mg
orally twice daily with pivampicillin 700 mg orally twice daily for
10 days in men with acute epididymitis and over 40 years of age.